AdaptHealth (AHCO)

• Market cap: $1.38B
• 1 day: 6.09%
• 5 days: 7.98%
• 1 month: 5.76%
• 3 months: -8.62%
• 6 months: -8.95%
• Year to date: 41.60%
• 1 year: 58.40%
• 5 years: -2.93%
• 10 years: 5.98%
• Sector: Healthcare
• Industry: Home Health Care Services

About: AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

Employees: 10,700

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

133% more call options, than puts

Call options by funds: $123M | Put options by funds: $52.8M

83% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 53

65% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 17

18% more capital invested

Capital invested by funds: $1.17B [Q2] → $1.39B (+$216M) [Q3]

5% more funds holding

Funds holding: 205 [Q2] → 216 (+11) [Q3]

3.88% more ownership

Funds ownership: 88.04% [Q2] → 91.92% (+3.88%) [Q3]

33% less funds holding in top 10

Funds holding in top 10: 3 [Q2] → 2 (-1) [Q3]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $11 7% upside
• Avg. target: $12.40 21% upside
• High target: $14 36% upside

5 analyst ratings

• positive: 5 100%
• neutral: 0 0%
• negative: 0 0%

RBC Capital Ben Hendrix 25% 1-year accuracy 18 / 71 met price target	7% upside $11	Outperform Maintained	19 Nov 2024
Truist Securities David Macdonald 56% 1-year accuracy 49 / 87 met price target	17% upside $12	Buy Maintained	15 Nov 2024
UBS Whit Mayo 59% 1-year accuracy 10 / 17 met price target	17% upside $12	Buy Maintained	6 Nov 2024
Canaccord Genuity Richard Close 50% 1-year accuracy 13 / 26 met price target	26% upside $13	Buy Maintained	6 Nov 2024
Baird Eric Coldwell 32% 1-year accuracy 11 / 34 met price target	36% upside $14	Outperform Maintained	6 Nov 2024